Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Weight Loss 1Preleukemia 1Ovarian Neoplasms 1Osteochondroma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Nevus, Epithelioid and Spindle Cell 1Myelodysplastic Syndromes 1Malnutrition 1Lung Neoplasms 1Hematologic Neoplasms 1Glioblastoma 1Giant Cell Tumors 1Gastrointestinal Neoplasms 1Fibrosis 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Merkel Cell 1Carcinoma, Lobular 1Carcinoma in Situ 1Barrett Esophagus 1

Interventions

Radiotherapy 4Carboplatin 4Trastuzumab 3Fulvestrant 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Paclitaxel 2Magnetic Resonance Spectroscopy 2Letrozole 2Docetaxel 2repotrectinib 1proto-oncogene protein c-fes-fps 1palbociclib 1neratinib 1gallium 68 PSMA-11 1fluciclovine F-18 1entrectinib 1Zolpidem 1Vorinostat 1Vinorelbine 1Venlafaxine Hydrochloride 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Sampling Studies 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiotherapy, Adjuvant 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Lobular × Sampling Studies × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡